Studies of SLC41A1, a Mg2+-Transporting Protein Linked to Parkinson's Disease
SLC41A1(一种与帕金森病相关的 Mg2 转运蛋白)的研究
基本信息
- 批准号:10711860
- 负责人:
- 金额:$ 38.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:Artificial MembranesBindingBinding SitesBiological AssayBiophysicsCarrier ProteinsCell LineCell physiologyCellsCellular AssayChemicalsCollaborationsCoupledCryoelectron MicroscopyDataDiseaseEnsureFunctional disorderGenesGrantHealthHealth systemHomeostasisHousekeepingHumanInvestigationIon ChannelIon TransportIonsKnock-outLipid BilayersLiposomesLuciferasesMagnesiumMeasuresMediatingMembraneMembrane PotentialsMetabolismMitochondriaModelingMolecularMutationNerve DegenerationNeurobiologyNeuroblastomaNeurodegenerative DisordersNeuronsOxidative PhosphorylationParkinson DiseasePathogenesisPermeabilityPrevention strategyProductionProteinsResearchResolutionRiskRoleSequence AlignmentSite-Directed MutagenesisStructureTestingTimeWaterWorkconformational conversioncostdesigndopaminergic neuronexperimental studyfluorescence imaginglink proteinmembermitochondrial membranenegative affectnew therapeutic targetnovelprofessorreconstitutionsolutevirtual
项目摘要
Project Summary/Abstract
Magnesium has been largely overlooked in neurobiology as a “housekeeping” ion, but this view is directly
challenged by evidence which shows that mutations in Mg2+ transporting proteins are associated with
neurodegeneration. Mutations in the Mg2+ transporting protein SLC41A1 are associated with both increased and
decreased risk of Parkinson's disease (PD). SLC41A1 might therefore be a causative gene for PD. Despite this,
little is known about SLC41A1. For example, we do not yet know if it causes rapid changes in free cytosolic Mg2+
(like an ion channel) or if it works to maintain the levels of free cytosolic Mg2+ within the range required for normal
cellular function (like a transporter). This distinction is required both to define the role of SLC41A1 in the Mg2+
homeostasis and its role in PD pathogenesis. Furthermore, a cellular role for SLC41A1 has not been determined
and it is therefore not known how its dysfunction might lead to PD.
We hypothesize that SLC41A1 is a Mg2+-permeable ion channel which, through its role in maintaining
the cellular Mg2+ homeostasis, helps maintain the mitochondrial membrane potential and ensures that ATP
production via oxidative phosphorylation proceeds undisturbed. In this application for a Stephen I. Katz ESI
grant, we propose to use liposomal flux assays and lipid bilayer studies as well as electron cryo-microscopy
(cryo-EM) to determine how SLC41A1 mediates Mg2+ transport, and to generate a model to determine its cellular
role.
Neuronal Mg2+ transport has thus far been virtually untouched by biophysical and structural investigation
and the study proposed here represents the first steps towards understanding the molecular mechanisms of
neuronal Mg2+ homeostasis as well as the Mg2+-dependent molecular origins of neurodegenerative disorders. In
the long term, this study of SLC41A1 has the potential to lead to novel treatments of and preventative strategies
against PD, a debilitating disease which costs the US health system more than $14 billion each year.
项目总结/摘要
在神经生物学中,镁作为一种“管家”离子在很大程度上被忽视了,但这种观点直接
有证据表明,Mg 2+转运蛋白中的突变与
神经变性Mg 2+转运蛋白SLC 41 A1的突变与Mg 2+转运蛋白的增加和
降低帕金森病(PD)的风险。因此,SLC 41 A1可能是PD的致病基因。尽管如此,
目前对SLC 41 A1的了解还不多。例如,我们还不知道它是否会导致细胞内游离Mg 2+的快速变化。
(like离子通道),或者如果它能将游离胞浆Mg 2+水平维持在正常细胞所需的范围内,
细胞功能(如转运蛋白)。这种区别是需要的,以定义SLC 41 A1在Mg 2+中的作用,
稳态及其在PD发病机制中作用。此外,SLC 41 A1的细胞作用尚未确定
因此不知道其功能障碍如何导致PD。
我们假设SLC 41 A1是一个Mg 2+可渗透的离子通道,通过其在维持细胞增殖中的作用,
细胞Mg 2+稳态,有助于维持线粒体膜电位,并确保ATP
通过氧化磷酸化的生产不受干扰地进行。在斯蒂芬一世的申请中。Katz ESI
格兰特,我们建议使用脂质体通量测定和脂质双层研究以及电子冷冻显微镜
(cryo-EM)以确定SLC 41 A1如何介导Mg 2+转运,并产生模型以确定其细胞内的Mg 2+转运。
作用
迄今为止,神经元Mg 2+转运几乎未被生物物理学和结构研究所触及
这里提出的研究代表了理解分子机制的第一步,
神经元Mg 2+稳态以及神经退行性疾病的Mg 2+依赖性分子起源。在
从长远来看,这项对SLC 41 A1的研究有可能导致新的治疗和预防策略。
PD是一种使人衰弱的疾病,每年花费美国卫生系统超过140亿美元。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lejla Zubcevic其他文献
Lejla Zubcevic的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Bridging the Gap: Next-Gen Tools for Accurate Prediction of Disordered Protein Binding Sites
弥合差距:准确预测无序蛋白质结合位点的下一代工具
- 批准号:
24K15172 - 财政年份:2024
- 资助金额:
$ 38.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design of protein crystal templates with multiple binding sites for tracking metal complex reactions.
设计具有多个结合位点的蛋白质晶体模板,用于跟踪金属络合物反应。
- 批准号:
23K04928 - 财政年份:2023
- 资助金额:
$ 38.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Dynamic changes in PIP2 binding sites and their impact on axonal targeting and function of epilepsy-associated KCNQ/Kv7 channels
PIP2 结合位点的动态变化及其对癫痫相关 KCNQ/Kv7 通道的轴突靶向和功能的影响
- 批准号:
10744934 - 财政年份:2023
- 资助金额:
$ 38.42万 - 项目类别:
Computational methods to identify small molecule RNA binding sites
识别小分子 RNA 结合位点的计算方法
- 批准号:
573688-2022 - 财政年份:2022
- 资助金额:
$ 38.42万 - 项目类别:
University Undergraduate Student Research Awards
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
- 批准号:
10704557 - 财政年份:2022
- 资助金额:
$ 38.42万 - 项目类别:
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
- 批准号:
10537846 - 财政年份:2022
- 资助金额:
$ 38.42万 - 项目类别:
Identifying new types of inhibitors in quinone binding sites in photosynthetic enzymes
鉴定光合酶醌结合位点的新型抑制剂
- 批准号:
2753921 - 财政年份:2022
- 资助金额:
$ 38.42万 - 项目类别:
Studentship
Development of broad nanovaccines targeting diverse coronavirus receptor-binding sites
开发针对不同冠状病毒受体结合位点的广泛纳米疫苗
- 批准号:
10328140 - 财政年份:2022
- 资助金额:
$ 38.42万 - 项目类别:
Exploiting Water Network Perturbations in Protein Binding Sites
利用蛋白质结合位点的水网络扰动
- 批准号:
10621368 - 财政年份:2021
- 资助金额:
$ 38.42万 - 项目类别:
SBIR Phase I: Nonlinear optical method for identifying protein-ligand binding sites
SBIR 第一阶段:识别蛋白质-配体结合位点的非线性光学方法
- 批准号:
2111821 - 财政年份:2021
- 资助金额:
$ 38.42万 - 项目类别:
Standard Grant














{{item.name}}会员




